all report title image
  • Published On : Dec 2019
  • Code : CMI1760
  • Industry : Medical Devices
  • Pages : 200
  • Formats :

Alcohol and drug testing equipment are used to test the level of intoxication caused by alcohol and drug in the body. Some of the equipment used for testing alcohol and drug content include breathalyzer, urine testing devices, oral testing devices, and hair testing devices, immune assay analyzers, and chromatographic instruments.  

The global alcohol breathalyzer and drug testing equipment market is estimated to be valued at US$ 5,215.4 million in 2022 and is expected to exhibit a CAGR of 6.3% during the forecast period (2022-2030).

Figure 1. Global Alcohol Breathalyzer and Drug Testing Equipment Market Share (%), by End User, 2022

Alcohol Breathalyzer And Drug Testing Equipment  | Coherent Market Insights

Increasing number of drunk and drive cases and drug addiction are expected to be major factors for increasing demand of alcohol breathalyzer and drug testing equipment, which is expected to drive the market growth over the forecast period

The increasing number of drunk and drive cases and drug addiction are expected to be major factors for increasing demand of alcohol breathalyzer and drug testing equipment. For instance, according to 2018 Fatal Motor Vehicle Crashes: Overview by the National Highway Traffic Safety Administration, a U.S. federal agency, 10,511 deaths were registered in the U.S. in 2018 due to drink and drive accidents. Moreover, according to the 2019 National Survey on Drug Use and Health (NSDUH), 85.6 percent of people ages 18 and older reported that they drank alcohol at some point in their lifetime, 69.5 percent reported that they drank in the 2021 year, and 54.9 percent (59.1 percent of men in this age group and 51.0 percent of women in this age group) reported that they drank.

CMI table icon

Alcohol Breathalyzer and Drug Testing Equipment Market Report Coverage

Report Coverage Details
Base Year: 2021 Market Size in 2022: US$ 5,215.4 Mn
Historical Data for: 2017 to 2020 Forecast Period: 2022 to 2030
Forecast Period 2022 to 2030 CAGR: 6.3% 2030 Value Projection: US$ 8,506.5 Mn
Geographies covered:
  • North America: U.S. and Canada
  • Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
  • Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
  • Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
  • Middle East: GCC Countries, Israel, and Rest of Middle East
  • Africa: South Africa, North Africa, and Central Africa
Segments covered:
  • By Equipment Type: Alcosensor (Fuel Cells), Breathalyzer (Semiconductor), Chromatographic Instruments, Hair Testing Devices (Kits), Immuno Assay Analyzers, Intoxilyzer (IR), Oral Fluid Testing Devices (Saliva), Urine Testing Devices (Kits, Cassettes, Cups, and Dips)
  • By Application: Alcohol Detection, Drug Detection
  • By End User: Federal Departments, Hospitals, Private Sectors, Rehabilitation Centers
Companies covered:

Dragerwerk AG & Co. KGaA, Quest Products, Inc., Intoximeters, Lion Laboratories Ltd., C4 Development Ltd., Alere, Inc., Lifeloc Technologies, BACtrack, Securetec Detektions-Systeme AG, and Andatech Private Ltd.

Growth Drivers:
  • Increasing number of drunk and drive cases and drug addiction are expected to be major factors for increasing demand of alcohol breathalyzer and drug testing equipment
  • Stringent government regulations and laws to reduce incidences of driving under influence of drugs and alcohol
Restraints & Challenges:
  • Inaccurate and wrong results provided by some breathalyzers
  • The low cost of alcohol breathalyzer and drug testing equipment manufactured by local players in the unorganized sector

Figure 2. Global Alcohol Breathalyzer and Drug Testing Equipment Market Share (%), by Region, 2022

Alcohol Breathalyzer And Drug Testing Equipment  | Coherent Market Insights

Stringent government regulations and laws to reduce incidence of driving under influence of drugs and alcohol are also expected to propel growth of the market.

Stringent government regulations and laws to reduce incidences of driving under influence of drugs and alcohol are also expected to propel growth of the market. For instance, the state government of New Jersey imposed new drunken-driving laws from December 1, 2019 that eliminates license suspensions for most first offenders, while requiring all motorists convicted of driving under the influence to install ignition interlocks, the in-car breathalyzers that immobilize a vehicle if the driver's breath registers too much alcohol.

Global Alcohol Breathalyzer and Drug Testing Equipment Market– Impact of Coronavirus (COVID-19) Pandemic

Since the COVID-19 virus outbreak in December 2019, the disease has spread to over 100 countries across the globe and the World Health Organization had declared it a public health emergency on January 30, 2020.

COVID-19 can affect the economy in three main ways: by directly affecting production and demand of drugs, by creating disruptions in distribution channels, and through its financial impact on firms and financial markets. Due to nationwide lockdowns, several countries, such as China, India, Saudi Arabia, U.A.E., Egypt, and others, are facing problems with regards to the transportation of drugs from one place to another.

However, the COVID-19 pandemic had a negative impact on the global alcohol breathalyzer and drug testing equipment market, owing to decrease in the drug testing activity. For instance, in October 2021, according to the data published by the National Center for Biotechnology Information, Lab-based urine testing, the gold standard for drug testing, remains the dominant drug testing method, but it notably slipped a few percentage points from 89 percent in 2020 to 85 percent in 2021. Meanwhile, employer use of less intrusive testing methods—lab-based oral fluid, hair testing, instant urine, and instant oral fluid testing—increased. Moreover, due to pandemic-related logistics and health concerns, it is harder to get traditional testing done, and many collection sites have also been performing COVID-19 testing. In response, employers compensated by moving to other testing options. Most employers, around 98 percent, perform some form of drug screening on their employees.

After a 15 percent decrease in drug testing from 2019 to 2020 for First Advantage clients, post-accident positivity rates soared by 17 percent across all industries. This trend is even more pronounced when compare post-accident positivity rates for customers who did perform pre-hire testing with those who did not. For those who did, their post-accident positivity rate rose 17 percent; however, the positivity rate doubled for those who did not perform pre-hire drug testing during that same time of COVID 19.

Global Alcohol Breathalyzer and Drug Testing Equipment Market: Key Developments

In July 2022, Cannabix Technologies Inc., a Vancouver-based technology company and developer of marijuana breathalyzer devices for law enforcement and the workplace reports that the company is participating in a new comprehensive multi-analysis study of subjects under the influence of marijuana. The new study will work alongside toxicologists and law enforcement officers in the southern U.S. In late June 2022, the Cannabix Technologies Inc., company participated in the first of three testing sessions that are expected to be held over the summer. The company has been coordinating for several months on its participation in this study with senior administrators. The study will test subjects under the influence of marijuana alongside several conventional drug screening methods (blood, oral fluid etc.), in conjunction with the use of Cannabix’s proprietary breath capture and marijuana detection equipment. Cannabix had granted use of its Breath Collection Unit and newly developed laboratory ‘MS Breath Sampler’ equipment to this important new research study focused on the detection of marijuana impairment in human subjects.

Global Alcohol Breathalyzer and Drug Testing Equipment Market: Restraint

The major factors that are expected to hinder growth of the global alcohol breathalyzer and drug testing equipment market include inaccurate and wrong results provided by some breathalyzers and the low cost of alcohol breathalyzer and drug testing equipment manufactured by local players in the unorganized sector. For instance, in November 2019, National Center for Biotechnology Information, investigation found that breathalyzer generate irregular results with alarming frequency, owing to improper calibration or improper programming in breathalyzer’s software.

Moreover, low cost of alcohol breathalyzer and drug testing equipment manufactured by local players in the unorganized sector is also expected to hinder growth of the overall market, especially in emerging markets. The cost of Alcohol Breathalyzer manufactured by local players is 20% – 30% less compared to those of established players in North America and Europe.

Key Players

Major players operating in the global alcohol breathalyzer and drug testing equipment market include Dragerwerk AG & Co. KGaA, Quest Products, Inc., Intoximeters, Lion Laboratories Ltd., C4 Development Ltd., Alere, Inc., Lifeloc Technologies, BACtrack, Securetec Detektions-Systeme AG, and Andatech Private Ltd.

A breath analyzer is also known as a ‘Breathalyzer’. It is a portable device used by the regulatory authorities across the world to identify if suspect has consumed alcohol above the permitted limits. In emerging and developed countries such as U.S., India, China, government are taking initiatives and enforcing safety laws related work safety issues. According to the Centers for Diseases and Prevention reports published in 2016, excessive alcohol use leads to around 88,000 death in the U.S. each year. Many organizations are now installing breathalyzer in their premises to keep a check on loss of work place productivity due to excessive drinking. Drug testing involves checking for substance use in people who do not necessarily have any symptoms of intoxication or a substance-related disorder. It may be done systematically or randomly in certain groups of people such as students, athletes, and prisoners. A drug test looks for signs of one or more illegal or prescription drugs in a sample of urine (pee), blood, saliva (spit), hair, or sweat. The purpose of a drug test is to look for drug use and misuse, which includes:

  • Using any illegal drugs, such as cocaine or club drugs
  • Misusing prescription medicines, which means taking prescription medicines in a different way or for a different purpose than one’s provider prescribed. Examples of drug misuse include using a prescription pain reliever to relax or taking someone else's prescription.

A drug test can check for a single drug or for a group of drugs in your body. Drug tests commonly test for:

  • Alcohol
  • Amphetamines, including methamphetamine
  • Barbiturates, such as phenobarbital and secobarbital
  • Benzodiazepines, such as alprazolam or clonazepam
  • Cocaine
  • Marijuana (THC)
  • Opioids and opiates, such as heroin, codeine, oxycodone, morphine, hydrocodone, and fentanyl
  • Phencyclidine (PCP)
  • Steroids

Market Dynamics

The rise in government programs and initiatives to control the accidents due to drink and drive situation is expected to drive the global alcohol breathalyzer and drug testing equipment. For instance, in August 2021, The Driver Alcohol Detection System for Safety (DADSS) Program started researching a first-of-its-kind technology that holds the greatest potential had to reverse testing of alcohol drink and drive trend. The technology will automatically detect when a driver is intoxicated with a blood alcohol concentration (BAC) at or above 0.08% — the legal limit in all 50 states except Utah — and prevent the car from moving. Once it has met rigorous performance standards, it will be voluntarily offered as a safety option in new vehicles — like automatic braking, lane departure warning and other advanced driver assist vehicle technologies.

Furthermore, in 2021, the Driver Alcohol Detection System for Safety (DADSS) Program announced the first-generation system equipped with the breath technology will be made available for open licensing in fleet vehicles for the first time ever. ACTS will begin licensing the technology to interested parties and a product equipped with the breath technology will be made available in late 2021 to any existing fleet or company that wants to outfit it into their vehicles – whether it be transportation vehicles, government fleets, rental cars, transportation vehicles, trucking companies, etc. This system is designed for fleet operators implementing a zero-tolerance alcohol policy for their drivers. Moreover, in 2021, the program announced the largest trial deployment of the driver alcohol detection system for safety technology to date, through a new trial deployment with truckload carrier Schneider. The pilot will help generate hundreds of thousands of real-world operating miles needed to commercialize fully passive vehicle-integrated breath technology — marking a new milestone toward the widespread deployment of the Driver Alcohol Detection System for Safety technology.

Key features of the study:

  • This report provides an in-depth analysis of the global alcohol breathalyzer and drug testing equipment market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022–2030), considering 2021 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global alcohol breathalyzer and drug testing equipment market  based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Dragerwerk AG & Co. KGaA, Quest Products, Inc., Intoximeters, Lion Laboratories Ltd., C4 Development Ltd., Alere, Inc., Lifeloc Technologies, BACtrack, Securetec Detektions-Systeme AG, and Andatech Private Ltd.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global alcohol breathalyzer and drug testing equipment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global alcohol breathalyzer and drug testing equipment market

Detailed Segmentation:

  • Global Alcohol Breathalyzer and Drug Testing Equipment Market, By Equipment Type:
    • Alcosensor (Fuel Cells)
    • Breathalyzer (Semiconductor)
    • Chromatographic Instruments
    • Hair Testing Devices (Kits)
    • Immuno Assay Analyzers
    • Intoxilyzer (IR)
    • Oral Fluid Testing Devices (Saliva)
    • Urine Testing Devices (Kits, Cassettes, Cups, and Dips)
  • Global Alcohol Breathalyzer and Drug Testing Equipment Market, By Application:
    • Alcohol Detection
    • Drug Detection
  • Global Alcohol Breathalyzer and Drug Testing Equipment Market, By End User:
    • Federal Departments
    • Hospitals
    • Private Sectors
    • Rehabilitation Centers
  • Global Alcohol Breathalyzer and Drug Testing Equipment Market, By Region:
    • North America
      • By Country
        • U.S.
        • Canada
    • Latin America
      • By Country
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • By Country
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Country
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • By Country
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Region:
        • South Africa
        • Central Africa
        • North Africa
  • Company Profiles
    • Dragerwerk AG & Co. KGaA *
      • Company Highlights
      • Products Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Quest Products, Inc.
    • Intoximeters
    • Lion Laboratories Ltd.
    • C4 Development Ltd.
    • Alere, Inc.
    • Lifeloc Technologies
    • BACtrack
    • Securetec Detektions-Systeme AG
    • Andatech Private Ltd.

“*” marked represents similar segmentation in other categories in the respective section.

Frequently Asked Questions

The global alcohol breathalyzer and drug testing equipment market size is estimated to be valued at US$ 5,215.4 million in 2022 and is expected to exhibit a CAGR of 6.3% between 2022 and 2030.
Factors such as increasing number of drunk and drive cases, drug addiction, and stringent government regulations and laws to reduce incidences of driving under influence of drugs and alcohol are expected to drive the market growth.
Hospitals is the leading end user segment in the market.
The major factors hampering growth of the market include inaccurate and wrong results provided by some breathalyzers and the low cost of alcohol breathalyzer and drug testing equipment manufactured by local players in the unorganized sector.
Major players operating in the market include Dragerwerk AG & Co. KGaA, Quest Products, Inc., Intoximeters, Lion Laboratories Ltd., C4 Development Ltd., Alere, Inc., Lifeloc Technologies, BACtrack, Securetec Detektions-Systeme AG, and Andatech Private Ltd.

Related Reports

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo